非小细胞肺癌放射性肺毒性的临床因素与细胞因子同剂量-毒性关系的交互作用
该研究基于125例I-III期NSCLC根治性放疗患者的前瞻性临床试验数据,评估将临床因素和细胞因子水平加入平均肺剂量(MLD)模型对≥3级放射性肺毒性(RILT)的预测价值,并探索这些因素如何与MLD效应交互。结果显示,加入临床特征和基线细胞因子后AUC从0.637升至0.669,中期细胞因子未进一步改善预测;30种细胞因子中有13种高水平降低MLD每Gy的RILT比值比,4种高水平则增强该关联。
要点
- 仅用MLD预测≥3级RILT的交叉验证AUC为0.637,log-likelihood为-28.2。
- 加入临床特征和基线细胞因子后AUC升至0.669,log-likelihood为-27.6。
- 中期细胞因子数据未进一步提高log-likelihood或AUC。
核心结论
- 细胞因子数据带来的额外预后获益有限,但理解临床和生物学因素与MLD-RILT关系的交互作用,为研究放射性毒性多因素机制提供了新框架。
研究设计与样本
- 分析2004至2013年四项前瞻性临床试验中125例接受根治性放疗的I-III期NSCLC患者数据。
- 在放疗前及治疗中第2、4周测量30种血浆细胞因子水平。
- 构建基于MLD、临床因素和细胞因子水平组合的惩罚逻辑回归模型。
- 采用交叉验证的log-likelihood和受试者工作特征曲线下面积(AUC)评估模型准确性。
主要发现
- 仅用MLD预测≥3级RILT的交叉验证log-likelihood为-28.2,AUC为0.637。
- 纳入临床特征和基线细胞因子水平后,log-likelihood提高至-27.6,AUC提高至0.669。
- 治疗中细胞因子数据未进一步提高log-likelihood或AUC。
- 30种细胞因子中,13种水平较高降低MLD对RILT的效应(对应每Gy MLD的RILT比值比降低),4种水平较高增强该关联。
临床怎么用
- 在MLD基础上可考虑结合临床特征和基线细胞因子水平以改善≥3级RILT的风险分层。
- 治疗中第2、4周细胞因子检测在本研究未显示额外预测增益,不宜常规用于改进MLD模型预测。
局限性
- 细胞因子数据带来的预后获益有限。
- 研究仅纳入I-III期NSCLC接受根治性放疗的患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Current methods to estimate risk of radiation-induced lung toxicity (RILT) rely on dosimetric parameters. We aimed to improve prognostication by incorporating clinical and cytokine data, and to investigate how these factors may interact with the effect of mean lung dose (MLD) on RILT. MATERIALS AND METHODS: Data from 125 patients treated from 2004 to 2013 with definitive radiotherapy for stages I-III NSCLC on four prospective clinical trials were analyzed. Plasma levels of 30 cytokines were measured pretreatment, and at 2 and 4weeks midtreatment. Penalized logistic regression models based on combinations of MLD, clinical factors, and cytokine levels were developed. Cross-validated estimates of log-likelihood and area under the receiver operating characteristic curve (AUC) were used to assess accuracy. RESULTS: In prognosticating grade 3 or greater RILT by MLD alone, cross-validated log-likelihood and AUC were -28.2 and 0.637, respectively. Incorporating clinical features and baseline cytokine levels increased log-likelihood to -27.6 and AUC to 0.669. Midtreatment cytokine data did not further increase log-likelihood or AUC. Of the 30 cytokines measured, higher levels of 13 decreased the effect of MLD on RILT, corresponding to a lower odds ratio for RILT per Gy MLD, while higher levels of 4 increased the association. CONCLUSIONS: Although the added prognostic benefit from cytokine data in our model was modest, understanding how clinical and biologic factors interact with the MLD-RILT relationship represents a novel framework for understanding and investigating the multiple factors contributing to radiation-induced toxicity.
引用
- Hawkins PG, Boonstra PS, Hobson ST, et al. Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship. Radiother Oncol. 2017. PMID: 28947099. doi:10.1016/j.radonc.2017.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。